iBankCoin
Home / 2013 / December

Monthly Archives: December 2013

12-30-2013 Trading Journal with emphasis on $GALE

Market decided to take another breather day by staying neutral once again.

Stock Gawd has favored me today once again as well.  As I’ve predicted last Friday, $GALE was either going to take the baton as a runner or it was going to run concurrently with $KNDI.  Well, as luck would have it, the latter was the ones happened today.

Why would $GALE continue to head higher?  I see there are two major catalysts that are favoring $GALE in the coming year- its rapid relief drug Abstral for breakthrough cancer pain and its pipelines of breast cancer treatment drug- NeuVax.

– $GALE management has the good foresight to secure the right to sell Abstral in the US.  And by doing so, $GALE may have hit the jackpot when no one is looking.  Take a look at $INSY. INSY Therapeutics Inc. is the major competitor to $GALE’s Abstral since it is selling their own version of Fentanyl sublingual drug similar to Abstral.  Yet, $INSY carries a market cap of $870 million compares to $GALE $507 million after today close.  While $INSY has other pipelines in the work, its main revenue generator, I believe, is its Fentanyl sublingual drug.

– With proper marketing, I believe $GALE can take market share away from $INSY giving enough time.  Thus, by its Abstral product alone, $GALE has the potential to be worth at least current market cap before counting its breast cancer NeuVax treatment.

– If there are any positive news from its NeuVax trial results, price has no where else to go but up and up.

This is why I’m not surprised to see $GALE bounce higher today.  Friday chart pattern told me it would go higher and it did.

Take a look at the daily chart below:

Gale_daily

Price has taken out the 12/5 high at $4.78 with volume higher than the last five days.  Momentum indicators below haven’t shown to be overbought yet; thus, I’m expecting this breakout to go higher this week.

Now look at the monthly chart below:

gale_monthly

Whoa! Did you see the breakout from the high of Dec 2010 at $4.08?  From a long-term perspective, $GALE has broken out of a three years high and the chart looks like it is going to go much higher.

Meanwhile, $KNDI did not disappointed.  Instead of handing the baton to $GALE, it ran side-by-side with it.   In the morning, I was struck by a strong urge to sell some $KNDI to lock in profit.  It was my swing trade mentality that kept urging me.  To counter this urge, I’ve to remind myself about the lost opportunity I had with $LNG.  Back in the early days when $LNG was trading around $5 bucks, I loaded up big and gave way to my urge and locked in profit around $7.  After that, due to volatility, I never got back in.  $LNG is now trading at $43!  With $LNG in mind, I was able to sit on my hands.

I’m sure it will be a wild ride here.  I’m expecting to see some profit-evaporation due to volatility and profit-taking.  And I’ll need to remain steadfast in holding my $KNDI position ’cause I know that if I try to swing trade, I’m going to mess up a good long-term trade here ’cause you will never know when the next surprise rally will hit this stock.

KNDI_daily

From the daily chart above, $KNDI gapped up nicely but ended a red bar.  That may not mean anything but room must be given for some correction and profit-taking.  I’m just satisfied that the last few days have helped my portfolio to regain higher ground.

Asides from $KNDI and $GALE, $AMRN also popped back up today.  I’m a firm believer that there is a possibility for FDA to reconsider $AMRN position and perhaps will meet $AMRN half-way in some fashion.  Furthermore, I’m impressed by the citizen petition that was submitted to the FDA by the grassroots organization called EPAdruginitiative.com.  Read the petition and you will understand why I decided to add more 2014 March $5 call option at 12 cents to increase my bet.  The way I see it, the reward far exceeds the risk many-times over if FDA turns a favorable corner.  If not, I won’t regret my bet since the potential loss is definitely manageable for me.

AMRN_daily

From the daily chart above, you can see a healthy bounce with price closing above the 5 & 15 MA lines.

I spoke too soon on Friday regarding $XONE.  Today, $XONE flip-flopped with $DDD and $SSYS with the former going down and the latter going up!  Oh well.  Nevertheless, I’m in the money with $XONE and is holding this one thru 2014.

$LRAD, $CERS, and $KGJI were not performing well today but its smaller corrections were totally masked by the gains from $KNDI, $GALE, and $AMRN.  Huge gains from $KNDI has given my portfolio another healthy gain.

Due to $KNDI continued price increase, it has become the largest position in my portfolio with $LRAD coming in second.

Current holdings:

KNDI, LRAD, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated).

I also increase my stake in $PHOT in my other account (the same one where I trade options) in preparing for Colorado to open its door to legal pot starting Jan. 1st, 2014.  Per the article here: Colorado To Blaze Marijuana Tourism Trail In 2014 With Legal Pot Shops, it stated:

Whether there will be enough pot to meet the expected rush next year is another matter altogether. State laws impeded efforts to ramp up production before Jan. 1, meaning it could take several months for supply to catch up with demand.

The way I look at it, I’m expecting to see a lot of will-be marijuana growers lining up in front of $PHOT door looking for financing to start their pot farming on Jan. 1st.  Hence my adding more to $PHOT today.

My 2 cents.

Comments »

12-27-2013 Trading Journal with emphasis on $KNDI

Market took a well-deserved breather today by staying neutral.

Meanwhile, I was sitting on a rocket that was going up, up and away…

Yes, $KNDI finally becomes relevant today.  How can it not be?  Take a moment to read the English Translation Transcript for the Q & A Session and Chairman’s Remarks for the 2013 Shareholders Meeting below at the bottom of this post.: (The bold areas are my own emphasis)

Below is the outline of the key points I’ve highlighted in the Q&A:

  1. The Company has made excellent Strides this year in expanding interest in the Car Sharing program through announced signed agreements in what appears to be at least five provinces to include Shanghai, totally covering over 250 million population.
  2. We expect there will be 2-3 cities launching the car sharing trials in 2014
  3. enable us to become the leading pure EV provider in China
  4. We expect this Car Share business model will be soon replicated into more cities throughout China

I’m sure there are many more key points in the Q&A but the above four are what I consider the most important to drive the $KNDI sales in 2014.  If anything, $KNDI may be conservative in their estimate; otherwise, why bother to expand manufacturing facilities as mentioned in Section 5 of the Q&A:

  • Q:The Company has announced new manufacturing facility building agreements in three other provinces-Hainan, Shandong and now Jiangsu – to add to our current reported total capacity of 130,000 EVs per year.

I do not know if price will continue to head higher from here or there will be profit-taking and a correction after today big-run.  However, any positive confirmations such as future earning reports, completion of car-sharing garages, implementation of car-sharing garages in new cities will definitely push price upward in the same manner as $TSLA meteoric rise we have witnessed this year.

Take a look at the daily chart below:

KNDI_daily

You can’t dispute the strength of today run-up. It cut thru the Sept 26 high like a hot knife thru butter.

And when you look at the monthly chart below; whoa! What we have is a new high for the last 6 years…

KNDI_monthly

As you can see, even the 5 MA line has a hard time following the strong uptrend.

Not to be overshadowed by $KNDI, $GALE and $XONE both had a strong showing today.

Take a look at the $GALE daily chart below:

Gale_daily

Price surely bounced off the 5 & 15 MA line with the 5 now ready to cross over the 15.  And from the two momentum indicators below, you can tell that the bounce is far from over.  Price looks like it may bounce higher soon.

$XONE performed miraculously in the 3D sector simply because it went up while the other two big siblings ($DDD and $SSYS) went down.

XONE_daily

Price is near the resistance point of $64.70 established back in Nov 14th.  I like to see price takes out that resistance soon.

The rest of the stocks in the portfolio pretty much cancelled each other with their minor ups and downs; so I won’t bother you with the charts on them.

Today was a good day for me giving that yesterday 20% run-up of $INO was followed by $KNDI 26% jump.  It was as though $INO passed the baton to $KNDI in a relay race to push my portfolio higher before reaching the end of the year.  Now, I’ll really like to see the baton passes on to $LRAD.  That will be quite a sight since $LRAD is my largest position so far.  Nevertheless, if $KNDI continues to run hard and fast next week, $LRAD may be displaced to become the 2nd largest position.

But giving the look on the chart, I see $GALE has the potential to be the next runner after $KNDI or in concurrent with $KNDI.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (full speculated); and yes, I still have my $PHOT on my other account.

My 2 cents.

———————-

Below is the English Translation Transcript for the Q & A Session and Chairman’s Remarks for the 2013 Shareholders Meeting below at the bottom of this post.: (The bold areas are my own emphasis)

The matters discussed at this shareholders meeting may include certain forward-looking statements that represent the Company’s expectations or beliefs. These statements by their nature involve substantial risks and uncertainties, which may be beyond the Company’s control. Actual results could differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those projected in the forward-looking statements is contained in our Annual Report on Form 10-K and elsewhere in the Company’s filings with the Securities and Exchange Commission. We encourage you to read these materials.

1.
Q: Geely and Kandi’s a 50-50 JV Partnership. How has Geely contributed to the JV in terms of distribution and marketing expertise?

A: The JV partnership with Geely is to develop EV programs in China; therefore, all the related EV programs will be included in JV. The goal for the JV is to implement Public EV sharing system. The resources of Geely and Kandi are available to be fully utilized for JV’s needs.

2.
Q: Geely has said it was turning over its extensive EV R & D to Kandi to lead Geely’s EV expansion; however Kandi has expressed no public interest to date in the “Full Sized EV” market. Is Kandi working with Geely or Volvo in developing “Full Size” EV’s for either Private or Taxi use and if so, is it as a “consultant” or will these cars be part of the JV?

A: The JV’s current panda 7001 pure EV is remodeled based on Geely’s original panda vehicle. There are also other models from Geely that are in the process of being remodeled. Volvo is a part of Geely; at the current stage, we aren’t working on any of Volvo’s vehicle models.

Q: Is there some future expectation of bringing the JV public and if so would it be in Hong Kong or Wall Street?

A: One of the major milestones we set up this year is the Joint venture with Geely Auto. We just completed the ownership transfer of Kandi Changxing to the JV Company. We truly believe this JV represents tremendous opportunities and values to Kandi’s shareholders going forward. At this point, we do not have any plan to list this company anywhere; our only plan is to make the best out of the JV partnership. , In the future, if there are any strategic benefits of listing the JV in Hongkong or mainland China, we will certainly update the market accordingly.

Q: The JV Agreement is very much like a black box – so far I see more Kandi activity than Geely activity. Can you provide a more detailed picture?

A: So far the joint venture agreement has illustrated the detailed collaboration between Kandi and Geely in terms of EV business in China. Our partnership has been working very well so far. All the news and effort you have seen in the press has been collectively from both Kandi and Geely.

3.
Q: To date there seem to be two EV’s included in the JV, the JNJ6290 and JL7002 Panda. The JNJ6290 while manufactured and sold by Kandi, is licensed under an agreement with Zoyte where it is understood that a small (300rmb) fee per car is paid to Zoyte.

A: JNJ6290’s license is now provided by Geely after the joint venture; this model will be renamed to be SMA7000BEV at the end of this month

Q: Will the Manufacturing and Sales of the JNJ6290 remain with Kandi, or will it be fully included in the JV where all future sales will be booked by the JV? If maintained by Kandi, but built in JV owned Changxing, how is the JV paid for the use of the facility?

A: Kandi will sell entire sets of parts of JNJ6290 to the JV, and the finished vehicle will be sold to the customers by the JV.

Q: Is it correct to assume that the co-developed Panda will be split 50-50 through the JV?

A: Yes, you may understand any EV under JV will be split 50/50.

Q: What is the average expected sales price of the JNJ6290?

A: The average expected sales price is about RMB 40,000 without batteries

Q: What is the average expected sales price of the JL7002?

A: The average expected sales price is about RMB60,000 without batteries

Q: What is the expected Service Life of each EV in a car sharing or leasing environment?

A: The subsidies term is 3 years, but we expect the service life will be approximately 5 years

4.
Q: Since September, the PRC Ministries have made two long awaited announcements regarding the subsidy programs. The first outlined the amount parameters and last monththe Ministries named the first 28 approved cities, which included Hangzhou, Jinhua, Shanghai, Jiangsu and Haiku, all cities that Kandi has an announced established presence. Has the actual payment of subsidies begun yet? If not, how soon is it expected?

A: We expect subsidies will begin to pay in the first quarter of 2014

Q:Can you tell us how manufacturers are to be paid the subsidies and are there additional subsidies provided by the Cities?

A:On September 17, 2013, the Ministry of Finance, the Ministry of Science and Technology, the Ministry of Industry and Information Technology and the National Development and Reform Commission (the “Four Ministries”) jointly issued Notice No. 551 of 2013, titling “Regarding the Continuous Promotion and Application of New-Energy Vehicles for the years from 2013 to 2015”. According to the new subsidy policy:

1. The subsidy payments will be distributed to the manufacturers on a quarterly basis in advance and the subsidies will then be paid by the manufacturers directly to the consumers.

2. Each local government is working on its own local level of supporting subsidy policy. We believe the local governments will soon announce their subsidy policies.

Q: Could you break down the amount of subsidies expected on each the JNJ6290 and JL7001?

A: Our understanding is that both car models will receive a subsidy of RMB 45,000 for each vehicle sold from the national government in 2014

Q: If subsidy payments have not yet started, can sales now be made before the actual start and subsidies still paid on these sales?

A:We believe as long as the car is sold during the subsidy period under the policy, it can receive the subsidy.

5.
Q: The Company has announced new manufacturing facility building agreements in three other provinces-Hainan, Shandong and now Jiangsu – to add to our current reported total capacity of 130,000 EVs per year. Are these all to be constructed within the JV?

A: Yes

Q:How are the capital requirements for the Hainan and Shandong manufacturing facilities to be/being met?

A: The JV will be responsible for raising the capital

Q:Will there be car leasing or car share programs in Hainan and Shandong and are they to remain as Kandi only or become JV programs? When do you anticipate to start?

A: All EVs that are manufactured by the JV will be used for the micro public transportation EV sharing program in China and they are getting ready to start.

Q:Are any facilities under construction yet and if so, when is completion expected on each?

A: The facility in Hainan is under construction now and is expected to be completed at the end of 2014 with the local support and assuming the weather and everything go well as planned.

The facility in Jiangsu is in the process of preparation and is also expected to be completed at the end of 2014 with the local support and assuming the weather and everything go well as planned.

As far as Shandong, we are making some strategic planning adjustments.

6.
Q: The Company has made excellent Strides this year in expanding interest in the Car Sharing program through announced signed agreements in what appears to be at least five provinces to include Shanghai, totally covering over 250 million population. What is the status of Shanghai which was announced a few months ago with anticipation of a trial program starting this year?

A: We have just launched the Carsharing program in Hangzhou and so far it has been well-received. At this point, there is no definite schedule for the trial program in Shanghai. Shanghai government is still working on selecting the location and other preparations.

Q:How many cities do you expect will at least have Car Sharing trials underway in 2014?

A: We expect there will be 2-3 cities launching the car sharing trials in 2014

Q: Please give an estimate of EV deliveries in 2013-Q4 from Kandi alone and from the JV?

A: We are expecting that there will be approximately 2,800 EVs to be delivered in Q4

Q:While 30 garages were originally anticipated to be completed in Hangzhou this year, future updates in August by the Company reported two open and 18 under construction. How many are now expected to be completed by December 31?

A:We expect there will be around 10 garages completed before Dec 31, 2013

Q: In terms of EV’s per location, what is the minimum and maximum?

A: Minimum is 30 and maximum is 300

Q: In percentage, what is the anticipated mix ratio between two and four door EVs? (ie. 80%-20%)

A: The current plan is 50/50 for each parking garage

Q: Have there been any problems getting all the needed systems to work as far as billing, etc for the garages?

A: So far everything goes well, as expected

Q:How many locations are expected in Q1 and by the end of 2014?

A: We expect to be over 50, but may be impacted by the weather and spring festival holidays

7.
Q: While the growth potential of Car Sharing easily numbers in the millions of cars over the next few years, little has been said about the long expected Hangzhou 20,000 Long Lease Program recently.

A: The 20,000 EV long term lease program is involved with the State Grid, China Aviation Lithium Battery Co., Ltd. and other related parties. The project has been progressing very slowly. The schedule is out of Kandi’s control and what we can do is to follow the State Grid’s plan. Our focus will turn to the micro public transportation EV sharing project.

Q: Has further development of this program simply been delayed by the delay of the PRC subsidy program, or is it being replaced by long term leasing through the Car Sharing Program?

A: We believe both have impacts

Q: Hong Kong Exchange listed Sinopoly and Kandi jointly announced in April that Sinopoly would be buying 1900 EVs from Kandi by this year end for the lease program. Will this still happen by this year end, or will it be extended into 2014?

A: It is a part of a long term lease project, and it’s slowly progressing. We will follow the State Grid’s plan on this project.

8.
Q: The Company should be congratulated by the recent battery purchase agreement with Premium supplier Wanxiang, particularly the excellent purchase terms. Which programs will they be supplying batteries for?

A: The majority of EVs of the current micro public transportation EV sharing project are using Wanxiang batteries.

Q: As is the case with Sinopoly, is it possible that Wanxiang will participate further than just supplying batteries?

A: We really value the opportunity of working with Wanxiang. We hope to work with them further in the future. However, currently we don’t have any plans.

Q: Will the Company start providing quarterly investor conference calls and some “guidance”, once sales start to normalize?

A: While we have confidence in launching our EV product offering in China, our progress is still in the early stages. The management is not ready to provide financial guidance at this point. However it’s our intention to keep shareholders well informed on the progress. The Company will provide quarterly investor calls when the time is appropriate.

9.
Others

Q: Since Kandi’s EV manufacturing capacity exceeds the demands of the Car Share and Car Leasing Programs, why are you not marketing plug-in EVs to individual buyers nationwide? Possibly via Geely’s showrooms? Can you see huge potential in this market?

A: Our EV manufacturing capacity has begun to rollout in 2013. Going forward in the near future, we believe our current manufacturing capacity is adequate to meet the market demand.

Q&A session ended

***

Final Remarks from Chairman and CEO, Mr. Hu Xiaoming:

Please allow me to make some ending remarks. Let me close by thanking you all for the support and patience you continue to give Kandi. I would also like to take this opportunity to thank all of the directors and management for their efforts and contribution this year. We are a company that tries our best to maximize our shareholders’ value. 2013 has been an excellent year for Kandi from many fronts:

First is the 50/50 joint venture with China’s largest privately owned auto manufacturer Geely Auto and we are grateful that Mr. Li Shufu serves as the Chairman of the JV Company, which we feel very proud about. In this JV, Kandi contributed many valuable assets, including the new full-scale EV production and assembly line in Changxing. Also, Geely’s subsidiary Shanghai Maple Guorun will soon complete the reform and reconstruction and become another EV production base for the JV Company, which will enable us to become the leading pure EV provider in China. Second is the micro public transportation EV sharing project in Hangzhou which was launched this year and has progressed pretty well. In 2014, we expect our EV business may surpass our legacy go-cart business and become a major revenue generator for the Company. We expect this Car Share business model will be soon replicated into more cities throughout China. Third is the national government subsidy policy renewal in September. With the government’s support, we expect EV sales will start to take off soon. We anticipate steady increasing demand for EVs in the coming year.

Finally, on behalf of the board of directors and the management, I would like to once again appreciate the support of all our shareholders. I assure all of you that Kandi’s management will work even harder in the coming year to enhance our product portfolio offering and further improve our communications, internal control, as well as the company transparency. I welcome you to visit our facilities in China and look forward to talking to you soon. With that, I would like to adjourn this 2013 annual shareholder meeting. Thank you very much! Wish all of you a wonderful holiday season.

 

Comments »

12-26-2013 Trading Journal with emphasis on $INO

And the market continued to reach new height to make way for 2014…

Meanwhile, $INO has another fantastic run-up day.  Compared to the last two run-up in the 2nd half of 2013, this run-up is based entirely on expectation instead of news released from the company.  The thing about expectation is that you never know when the run is over.  In other words, we never know where the price point for this renewed expectation.

ino_daily

From the daily chart, you can see that the 79 & 89 MA lines are in an uptrend.  Not only that, these two magical lines are able to support the corrections from the last two run-ups.  For a biotech company to test the previous highs of the last two run-up within a 5-month periods, I’ve to say that $INO has a lot of believers as well as investors who want to see $INO succeeds for the benefits of the human race.  Make no mistake, if the trial result in mid-2014 proves positive, the implication is a disruptive bio-technology that will surely revolutionize vaccines technology.  Not to mention the positive expectation on the multiple pipelines $INO is currently working on.

Can $INO synthetic vaccines work this time when so many others have failed?  Will they finally get it right this time to merit a positive trial result?  Could past failures point $INO to the right path in making synthesis vaccines to work in human?  We will soon find out by mid-2014 with their cervical cancer trial result.  Previous run-up had been based on fantastic news from positive preclinical results on mice.  And a jump from mice to human will require a lot of “tweaking” in the labs to make it works on human.  I’m crossing my finger that the $INO has finally tweaked its synthesis vaccine to the point that it will work on our human body.

Having said that, $INO is still a speculative bet.  A bet that if won, a blast-off in price will result; and if failed, be prepared to say good-bye to your investment.  And that is why I’m investing only a mid-size position in comparing to my previous big bet on the first run back in August.  With a mid-size position, I no longer need to watch it like a hawk and be quick on the trigger.  I can just let it ride amidst the volatility.

INO_monthly

Take a look at the monthly chart above, price has already climbed above all MA lines. Even the 89 MA is now beginning to point up.  It looks like price is getting ready to make history next year, the year of 2014.

For all intent and purpose, all the stocks in my portfolio are chosen for its potential explosive run-up in 2014.

$KNDI did well today by heading higher albeit only 2.63%.  As long as price can continue its momentum to the upside, I’m happy.

KNDI_daily

I like the fact that the 5 MA line is now pointing back up.  There is a lot of potential for $KNDI in 2014.  All we need to hear next year is the completion of more and more car-sharing garages in multiple cities in China.  I truly believe the business model of selling the EV to car-sharing garages as opposed to consumers directly is the KEY to getting EV out on the roads.  I’m very confident that $KNDI (by partnering with Geely- one of the largest car manufacturer in China) will succeed in leaps and bounds in this car-sharing direction.

$XONE continued to head higher today and I like to see it take out $100 next year.

XONE_daily

Price has finally bounced away from the 79& 89 MA lines with the 5 MA pointing up.

$GALE is another speculative bio-tech I like that may flourish in 2014.  Today small increase continued to support the current consolidation instead of developing a downward trend.

Gale_daily

The underlying tone, as can be seen by the two momentum indicators below as well as the 5 MA line starting to point up, is still bias on the long side.  I can see price pop either into the year-end or early next year.

Thanks to $INO, $KNDI, $XONE, and $GALE, my portfolio has another healthy gain today.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated).

My 2 cents.

Comments »

12-24-2013 Trading Journal

Without a doubt, X’mas rally has been validated by another fine up day on X’mas Eve.

$KNDI started off with a big bang and traded as high as $8.57 before settled down to close at $8.00.

KNDI_daily

There is no question that the downtrend line has been breached and price is now looking to head higher from here.  While price did not close near the high, it did close up 4%.  This is good enough for me.  When you look at it from a long-term perspective, it really doesn’t matter if price closes near the high or not ’cause you are looking for a much higher price than today trading range.  Therefore, all I care is that the uptrend is intact.

Next, $CERS continued to surge higher.

CERS_daily

Price is now very near the downtrend line and it will not take much to walk over it later this week.  I expect to see much higher price in 2014 simply because I’m confident that they can get FDA approval to sell their products in the U.S.  (Be aware that my confidence in $AMRN has taken me to a cleaner the last few years; in other words, I can be very wrong sometimes.)  $CERS products have been selling in Europe without incident so I don’t see any issue that the FDA may find in $CERS U.S.  trial results   With approval, this stock will take off like a ….

I was glad to see $KGJI bounced today ’cause I needed to see price bounced off the 89 XMA line.

KGJI_daily

Price action closed above both 79, 89, and 5 MA lines today with both momentum indicators continued to point up.  Let’s see if price can bounce higher from here.

$INO did not disappointed since price moved higher and away from the resistance and now support line at $2.38.

ino_daily

Next target is $2.90 and after that $3.0.

$XONE had a crazy day when price dropped an astounding $5+ from today high.  Miraculously, price recovered to close only .$0.52 or -.88% as opposed to  around -5% for $DDD and $SSYS.

XONE_5m

I chose $XONE for its focus on manufacturing angle; and it is probably because of this angle that $XONE survives the downdraft on 3-D printing companies today.

Both $GALE and $AMRN had a negligible correction that did not warrant me to put up a chart for review.

Overall, thanks to $KNDI, $CERS, $KGJI, $LRAD, and $INO, my portfolio has a healthy gain today.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (full speculated)

My 2 cents.

Happy Holiday and thanks for reading my blog!

Comments »

12-23-2013 Trading Journal

Market continued to move higher today. One more day of convincing nonbelievers that X’mas rally is for real.

But in my case, my portfolio had a Santa and a nonbeliever working together today; one cancelled the other.

$LRAD, $KGJI, and $AMRN (nonbelievers) corrected but thanks to $INO, $XONE, and $KNDI (Santa), my portfolio was practically unchanged.

$KGJI gave back a chunk of gain from Friday but at low volume; thus, this one still had a lot of nonbelievers to work off.

KGJI_daily

Notice that price landed right on the 89 XMA line. I like to see price bounces back up tomorrow.  Since $KGJI is a fairly large position, the give back is substantial.

Fortunately, $XONE bounced hard today.

XONE_daily

Notice how price action took out the previous pivot-high from Dec 4th at $57.65.  This is a very bullish bounce.

$INO also had a strong breakout today.

ino_daily

Notice how price action took out TWO resistance lines today- one from Nov 25th at $2.24 and $2.38 from Oct 8th.

Although $KNDI was up today, it was still struggling to stay above the downtrend line.

KNDI_daily

Price still stays above the 15 MA line and the 79 & 89 are still pointing up; so the overall trend is still up.

$AMRN was down today but this was to be expected after a big 25% up day from last Friday.

AMRN_daily

Price is still above the Friday low which I see at a positive sign.

Meanwhile, $CERS continued to march ahead.

CERS_daily

Price is now closing above all MA lines.

$LRAD correction today confirms that it is now in a consolidation phase b/w $2 and $1.8x waiting for news to bounce.

LRAD_daily

Any big order news from China will drive this one up over $2 very quickly.  Meanwhile, patience is required.

$GALE is also consolidating in a tight range b/w $4.20. and $3.85.

Gale_daily

Notice how the 5 MA line is beginning to turn up.  Let’s see if there is a bounce this week before the year end.

Since I believe in $TINY to be relevant only in 2014, it is still worthy of mentioning here.

TINY_weekly

Based on the weekly chart,above, today bounce may signify a bottom here at around $3.00.

While my portfolio is at breakeven point today, the underlying strength is strong in my opinion.  Thus, I’m looking forward to the weeks ahead.

Current holdings:

LRAD, KNDI, KGJI, CERS, INO, XONE, GALE, AMRN, TINY (fully speculated)

My 2 cents.

Comments »

12-20-2013 Trading Journal

The Dow Jones Industrials closed at historical high while the SP500 closed below but still bullish nevertheless.

Meanwhile, I had three stocks that recovered strongly that helped my portfolio bounced solidly today.

$AMRN bounced 25.79% higher, $KGJI 15.38%, and; $CERS 4.97% higher.  With the exception of $GALE, the rest bounced slightly.

Fate had it that $NUGT stopped me out yesterday that prompted me to look at $AMRN; otherwise, I would be watching $AMRN bounce with pain in my heart since I had sat in this one for years with every ounce of conviction that I could muster.  I’m curious if we are seeing the bottom of $AMRN here.  While the FDA is merely delaying the decision that was due today; it opens the possibility that it may consider giving $AMRN some rope for its Vascepa label expansion.  At this stage, any rope, even for an inch, will open the door for $AMRN to recover from its current situation.

AMRN_daily

While today bar chart didn’t close above the last resistance at $2.07, it is not that far off from it.  Let’s see if there are enough believer going forward to buy the price back up to the Jan 15 decision day.

$KGJI strong green bar coupled with high volume and turning up of the momentum indicators all points to a future rally here.

KGJI_daily

Notice that today price action closed above all the MA lines.

KGJI_weekly

The weekly bar above is even more bullish. See how price closed above the 89 XMA as well as the 5 and 15 MA lines?  From the weekly chart, this speaks much louder than the daily chart.  The bounce is in and $KGJI is heading higher from here.

$CERS is definitely bouncing away from the support line at $5.7x.

CERS_daily

One look at the chart and you can expect to see the bounce will continue on.  Both momentum indicators are turning up with high volume.

Since $KGJI and $CERS are my third and fourth largest position in the portfolio with $AMRN being 50% in size relatively, I expect any strong rally from here for these three stocks will carry my portfolio to higher ground.  Not to mention that the rest of my stocks all have the potential to do the same in 2014 and beyond.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, AMRN, TINY (fully speculated).

Btw, giving the Dow Jones Industrials is making new historical high today, I congratulate everyone who is loaded on equity.  For those who is still waiting on the sideline, you know that price inflation will eventually wipe you out despite the government stance that there is no inflation.  The stock market is a major source of protection against inflation in a growing economic environment.  In other words, you are never safe in heavy cash position while the market continues to head higher.  The universe is always expanding, so is the market.

My 2 cents.

Comments »

12-19-2013 Trading Journal

Market tried to correct but ended the day nearly neutral.

$NUGT gapped down and I placed a stop below intra-day low instead of outright getting out.  Nope, no luck.  I was stopped out anyway.  I took my losses and moved on.  With the newly released fund, what should I buy?

Then I started looking at $AMRN again. Are you crazy?

What if for some exotic reason the FDA decides to offer some half-way measured approval for Vascepa?  What if…  What if…

Enough what if already; thus I bought back $AMRN with the available cash just to shut myself up.

Now, if $AMRN shoots up tomorrow (long shot), then I’ve $NUGT to thanks for.  Without $NUGT stopping me out today, I wouldn’t have bought $AMRN.  OK, enough talking on my part, let’s roll the dice!

I was hit hard today by $KNDI and $KGJI; thus despite an up day for $LRAD, I’m still under water a bit today.

Nevertheless, for the long-term hold on most of these hi-beta stocks, today hiccup is just your standard cup of tea.  Nothing to sweat about.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, TINY, AMRN (fully speculated)

My 2 cents.

Comments »

12-18-2013 Trading Journal

Market began by trading down and then spiked up big time in mid-day.

Unfortunately, my portfolio wasn’t able participate in this relative giant rally.

I did change the overall structure of my portfolio by reducing $CERS, $GALE, $TINY to buy $INO.

ino_daily

From the chart, $INO looks like it is going for another test against the resistance at $2.24.  Price is now above all the MA lines.

$NUGT suffered today due to the huge rally in equity.

NUGT_daily

If it takes out the support at $25.2x, I will have to cut my losses once again.

Current holdings:

LRAD, KNDI, KGJI, CERS, XONE, INO, GALE, TINY, NUGT and 1% cash.

My 2 cents.

Comments »

12-17-2013 Trading Journal

After a jump yesterday, the market decided to take an early break by taking a minor correction.

Meanwhile, I used the released cash to buy back some $XONE and $GALE I sold yesterday.

Thanks to $LRAD having an up day, it took my portfolio higher today despite some minor dips from $CERS, $KGJI, and $NUGT.

LRAD_daily

The chart looks bullish overall, You can see that the bounce takes the price above the 5 and 15 MA lines.

The weekly chart looks even better.

LRAD_weekly

See how the 5 MA line is moving higher with price closing above it?  Most important of all, price remains above the breakout line.

$KNDI remained positive although percentage was small.

KNDI_daily

What I care most about is that price remains above the downtrend line.

Current holdings:

LRAD, KNDI, CERS, KGJI, TINY, GALE, XONE, NUGT and 2% cash.

My 2 cents.

Comments »

12-16-2013 Trading Journal

Market opened higher and it was a much needed bounce to add to the belief that this uptrend is not over yet.

Due to rally after the open on $NUGT, I added.  And when the rally proved to be persistent (in the morning still), I sold almost half of $XONE to cut losses and moved the fund to $NUGT.

NUGT_daily

Notice price is still struggling to maintain bounce.  Why am I looking into picking bottom on $NUGT here?  You may wonder…

I’m convinced that gold may be bottoming here because the monthly chart of $GLD is now reflecting a 50% correction from historical low and high.

GLD_monthly

Did you see how the 50% retracement is landing right on the 79 & 89 MA lines?  These kind of visual support is what give me the confidence to buy “potential” bottom with small risk.

While I like $XONE to be long-term play, I’m still subjected to the pull of the chart patterns.  $XONE took out yesterday low so I had no problem letting some shares go to add to $NUGT.

XONE_daily

If $XONE can bounce off the support (blue line), I may buy back shares I sold with cash from sales of some $GALE.

$GALE took out last Thursday low and price fell below the 5 and 15 MA lines.  Even worse, the 5 had crossed below the 15 MA line as well; hence my lightening up $GALE position by 1/3 today to raise cash and reduce risk.

Gale_daily

I still think $GALE will rally later so I’m looking to buy back cheaper if possible.

$KNDI rallied strong after open but gave back most of the gain later in the day.  The good news is that price closed higher for the day.

KNDI_daily

Notice that I re-drew the downtrend line to align with the high of previous bars which put today at a breakout day instead of last week.  If this week can maintain momentum, we may see a solid up bar by end of week.

Glad to see $CERS bounced today ’cause I needed the confirmation that the support line is holding.  It is so far.

CERS_daily

Now, $CERS need to continue to bounce to move away from the support line.  The sooner it gets back above the 79 & 89 MA lines, the less stress it will be on my portfolio.

$LRAD, $KGJI and $TINY are still struggling to maintain ground; thus, even with DOW up over 100 points today, my portfolio was at breakeven where small gains on some positions offset small losses on others.

Current holdings:

LRAD, KNDI, CERS, KGJI, TINY, GALE, NUGT, XONE and 5% cash.

My 2 cents.

Btw, $PHOT is doing FANTASTIC on my other broker account.  Because this is a long-term hold for me, I may see some give back of unrealized gain due to profit-taking sooner or later.

Comments »